Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
This study was done to look at the level of Depo-Provera, an injectable birth control, in the
blood to see whether it is affected by the anti-HIV drug Kaletra (lopinavir/ritonavir
[LPV/r]). It is not known whether taking Depo-Provera together with Kaletra changes the
amount of Kaletra in blood. Therefore, this study also looked at the levels of HIV and
Kaletra before and after receiving a shot of Depo-Provera. This study evaluated the safety of
Depo-Provera and Kaletra when they are used together. In addition to what is stated above,
this study also explored any effect of Depo-Provera on the immune system.
Phase:
Phase 2
Details
Lead Sponsor:
AIDS Clinical Trials Group
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)